DIY healthcare tops PwC’s HRI 10 issues for 2015
PwC’s Health Research Institute (HRI) announced its top 10 health industry issues for 2015.
PwC’s Health Research Institute (HRI) announced its top 10 health industry issues for 2015.
The HRI’s top three emphasizes the possibilities of mobile device technologies for do-it-yourself (DIY) healthcare and the potential privacy concerns that could arise.
The list also highlights high-cost patients and the need for innovations that reduce cost and improve outcomes (#’s four and five).
Rounding out the top 10: transparency initiatives targeting clinical trial data, the emerging portrait of the newly-insured, physician “extenders” in the first line of care, redefining health and well-being for the millennial generation and partnerships pushing healthcare companies toward new competitive strategies.
PwC compiles the top list via a survey of 1,000 U.S. consumers and interviews with health industry leaders, according to its press release.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
